Chronic hyperglycemia affects bone metabolism in adult zebrafish scale model
- 749 Downloads
Type II diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia that induce other pathologies including diabetic retinopathy and bone disease. The mechanisms implicated in bone alterations induced by type II diabetes mellitus have been debated for years and are not yet clear because there are other factors involved that hide bone mineral density alterations. Despite this, it is well known that chronic hyperglycemia affects bone health causing fragility, mechanical strength reduction and increased propensity of fractures because of impaired bone matrix microstructure and aberrant bone cells function. Adult Danio rerio (zebrafish) represents a powerful model to study glucose and bone metabolism. Then, the aim of this study was to evaluate bone effects of chronic hyperglycemia in a new type II diabetes mellitus zebrafish model created by glucose administration in the water. Fish blood glucose levels have been monitored in time course experiments and basal glycemia was found increased. After 1 month treatment, the morphology of the retinal blood vessels showed abnormalities resembling to the human diabetic retinopathy. The adult bone metabolism has been evaluated in fish using the scales as read-out system. The scales of glucose-treated fish didn’t depose new mineralized matrix and shown bone resorption lacunae associated with an intense osteoclast activity. In addition, hyperglycemic fish scales have shown a significant decrease of alkaline phosphatase activity and increase of tartrate-resistant acid phosphatase activity, in association with alterations in other bone-specific markers. These data indicates an imbalance in bone metabolism, which leads to the osteoporotic-like phenotype visualized through scale mineral matrix staining. The zebrafish model of hyperglycemic damage can contribute to elucidate in vivo the molecular mechanisms of metabolic changes, which influence the bone tissues regulation in human diabetic patients.
KeywordsZebrafish Scale Type 2 diabetes mellitus Osteoporosis Bone
This work was supported by Ricerca Corrente funds of the Ministero della Salute (Italy).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 3.N. Napoli, R. Strollo, A. Paladini, S.I. Briganti, P. Pozzilli, S. Epstein, The alliance of mesenchymal stem cells, bone, and diabetes. Int. J. Endocrinol. 2014, 690783 (2014)Google Scholar
- 6.N. Ogawa, T. Yamaguchi, S. Yano, M. Yamuchi, M. Yamamoto, T. Sugimoto, The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm. Metab. Res. 39(12), 871–875 (2007)CrossRefPubMedGoogle Scholar
- 11.E. de Vrieze, J.R. Metz, J.W.V. Hoff, G. Flik, ALP, TRAcP and cathepsin K in elasmoid scales: a role in mineral metabolism? J. Appl. Ichthyol. 26(2), 210–213 (2010)Google Scholar
- 14.N. Suzuki, M. Yamamoto, K. Watanabe, A. Kambegawa, A. Hattori, Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: the scale is a good model for the evaluation of heavy metals in bone metabolism. J. Bone Miner. Metab. 22(5), 439–46 (2004)CrossRefPubMedGoogle Scholar
- 15.M. Westerfield., The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 5th edition. University of Oregon Press, Eugene, 2007Google Scholar
- 28.K.H. Ding, Z.Z. Wang, M.W. Hamrick, Z.B. Deng, L. Zhou, B. Kang, S.L. Yan, D.M. She, D.M. Stem, C.M. Isales, Q.S. Mi, Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem. Biophys. Res. Commun 340(4), 1091–1097 (2006)CrossRefPubMedGoogle Scholar